Loading...
Uploaded by CDNCancerSociety on Oct 18, 2011
A Canadian Cancer Society funded clinical trial has found that men treated with alternating courses of hormone-suppressing therapy will live as long as those receiving continuous therapy, while experiencing fewer side effects.
Nonprofits & Activism
Standard YouTube License
This is an interesting report and one that I will be sure to share with my friends. Thank you for bringing the results forward!
kazanlaw 4 months ago
This is an interesting report and one that I will be sure to share with my friends. Thank you for bringing the results forward!
kazanlaw 4 months ago